|
NECAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19380000002312E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.91369999999769E-06 |
| Normal-vs-Stage2 |
8.748100E-02 |
| Normal-vs-Stage3 |
4.273700E-02 |
| Normal-vs-Stage4 |
2.259200E-01 |
| Stage1-vs-Stage2 |
3.713600E-01 |
| Stage1-vs-Stage3 |
4.959400E-01 |
| Stage1-vs-Stage4 |
8.055200E-01 |
| Stage2-vs-Stage3 |
7.965200E-01 |
| Stage2-vs-Stage4 |
7.226800E-01 |
| Stage3-vs-Stage4 |
8.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39279999999964E-06 |
| Normal-vs-AfricanAmerican |
8.223900E-03 |
| Normal-vs-Asian |
4.786600E-01 |
| Caucasian-vs-AfricanAmerican |
4.054400E-01 |
| Caucasian-vs-Asian |
5.906800E-01 |
| AfricanAmerican-vs-Asian |
8.299200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49129999999143E-06 |
| Normal-vs-Female |
1.321920E-03 |
| Male-vs-Female |
5.361400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.227510E-04 |
| Normal-vs-Extreme_Weight |
3.90420000000447E-05 |
| Normal-vs-Obese |
3.237200E-03 |
| Normal-vs-Extreme_Obese |
3.330300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.830400E-01 |
| Normal_Weight-vs-Obese |
2.985200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.052800E-01 |
| Extreme_Weight-vs-Obese |
4.479800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.273800E-01 |
| Obese-vs-Extreme_Obese |
4.735000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.461200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.883750E-03 |
| Normal-vs-Age(61-80Yrs) |
3.20519999985613E-07 |
| Normal-vs-Age(81-100Yrs) |
8.478400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.263000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.018290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.273600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.288500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.690400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.29149999999567E-05 |
| Normal-VS-Type2 PRCC |
1.359770E-04 |
| Normal-VS-KIRP CIMP |
2.098400E-02 |
| Normal-VS-Unclassified PRCC |
3.541200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.719400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.317200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.586300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.184600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.435600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.494980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.361300E-04 |
| Normal-vs-N1 |
3.872400E-02 |
| Normal-vs-N2 |
4.593000E-01 |
| N0-vs-N1 |
7.728400E-01 |
| N0-vs-N2 |
4.716200E-01 |
| N1-vs-N2 |
6.037000E-01 |
|
|
